PMC:7283670 / 78869-79253
Annnotations
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T431 | 151-159 | Disease | denotes | COVID‐19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T314 | 98-100 | Chemical | denotes | LV | http://purl.obolibrary.org/obo/CHEBI_73579 |
| T315 | 122-129 | Chemical | denotes | antigen | http://purl.obolibrary.org/obo/CHEBI_59132 |
| T316 | 292-294 | Chemical | denotes | LV | http://purl.obolibrary.org/obo/CHEBI_73579 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T698 | 0-384 | Sentence | denotes | Immunity and safety of Covid‐19 synthetic minigene vaccine Biological: injection and infusion of LV‐SMENP‐DC vaccine and antigen‐specific CTLs China/COVID‐19 100, all, 6 months to 80 years Treatment Experimental: pathogen‐specific DC and CTLs patients will receive approximately 5 × 106 LV‐DC vaccine and 1 × 108 CTLs via subcutaneous injections and iv infusions, respectively I |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 1935 | 248-256 | Species | denotes | patients | Tax:9606 |